13/05/2021
The gap between the first and second doses of the Covishield COVID-19 vaccine can be increased to 12-16 weeks - from the existing six-eight weeks - the centre said Thursday evening. No changes have been announced in dosage intervals for Covaxin, which remains at four to six weeks.
"Based on available real-life evidence, particularly from the United Kingdom, the COVID-19 Working Group has agreed to increase dosing interval between two doses of the Covishield vaccine to 12-16 weeks. No change in intervals for Covaxin was recommended," the centre said.
The recommended interval changes were accepted Wednesday by the National Expert Group on Vaccine Administration and by the Union Health Ministry today.